BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 378323)

  • 21. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
    Brodie NH
    Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
    Becker HM; Elert O; Häring R; Maurer PC; Raithel D; Sperling M; Stockmann U; Storz LW; Hirche H
    Med Welt; 1979 Oct; 30(43):1602-6. PubMed ID: 514039
    [No Abstract]   [Full Text] [Related]  

  • 23. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of cerebrovascular disorders. 2. Blood pressure control in cerebrovascular disorders (during the acute and chronic stages)].
    Fujishima M
    Nihon Naika Gakkai Zasshi; 1991 Apr; 80(4):553-8. PubMed ID: 2061632
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug therapy: cerebral vasodilators (first of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(25):1508-13. PubMed ID: 7029283
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 27. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
    Schmidt C; Royer RJ; Kissel P
    Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroimaging in acute or subacute stroke: present choices and future possibilities.
    Babikian VL
    J Neuroimaging; 1997 Apr; 7(2):118-9. PubMed ID: 9128452
    [No Abstract]   [Full Text] [Related]  

  • 30. [Naftidrofuryl in patients with prosthetic femoral-popliteal bypass].
    Noppeney T; Kasprzak P; Raithel D; Hirche H
    Vasa Suppl; 1988; 24():60-6. PubMed ID: 3062825
    [No Abstract]   [Full Text] [Related]  

  • 31. The usefulness of naftidrofuryl in severe peripheral ischaemia--a symptomatic assessment using linear analogue scales.
    Meehan SE; Preece PE; Walker WF
    Angiology; 1982 Oct; 33(10):625-34. PubMed ID: 6751162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of blood flow changes in chronic peripheral ischemia in relation to surgical or pharmacological hyperemizing therapy].
    Florena M; Cortese LF; Ruscazio M
    Minerva Cardioangiol; 1979; 27(1-2):51-60. PubMed ID: 471236
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benfurodil hemisuccinate in cerebrovascular pathology].
    Lehembre P; Warot P
    Lille Med; 1974 Apr; 19(4 Suppl 11):525-7. PubMed ID: 4612281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Naftidrofuryl. (Pralixene)].
    Naess K
    Tidsskr Nor Laegeforen; 1980 Mar; 100(8-9):518-9. PubMed ID: 7385216
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of naftidrofuryl on pathological EEG topography.
    Foit A; Bischoff W; Breinlinger U; Kornhuber HH
    Vasa Suppl; 1988; 24():56-9. PubMed ID: 3212605
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy of intermittent claudication in the IIb stage of arterial occlusive disease].
    Kriessmann A; Neiss A; Lutilsky L; Beermann M; Kramann B
    Med Welt; 1979 Jun; 30(23):888-91. PubMed ID: 459805
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic use of naftidrofuryl (Praxilene)--peripheral vascular disease.
    Forrest H
    Scott Med J; 1978 Jan; 23(1):45-6. PubMed ID: 635540
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A; Neiss A
    Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
    [No Abstract]   [Full Text] [Related]  

  • 39. [Naftidrofuryl--a new direction in angiologic therapy. Symposium of the 17th annual meeting of the German Society of Angiology. Esslingen, 1988].
    Vasa Suppl; 1988; 24():1-75. PubMed ID: 3212597
    [No Abstract]   [Full Text] [Related]  

  • 40. Naftidrofuryl and the nitrogen, carbohydrate, and lipid responses to moderate surgery.
    Burns HJG
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):1002-3. PubMed ID: 6435723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.